Nominate: Xconomy Awards →
June 8, 2020 · National
September 1, 2020 · San Francisco
October 1, 2020 · New York
Infinity Pharmaceuticals CEO Adelene Perkins and R&D head Julian Adams. Photo courtesy of Infinity Pharmaceuticals.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
A growing nationalist and protectionist mindset around the world is creating a fresh set of challenges for global businesses
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.